Abstract
Antibiotics are routinely used in woundcare for the treatment of local and systemic infections. Our goals in this paper were to (i) evaluate the antibiotic sensitivity of bacteria isolated from burn and chronic wounds and (ii) evaluate the effect of pH and bacterial phenotype on the efficacy of antibiotics. Chronic and burn wound isolates, which had been routinely isolated from patients at West Virginia University Hospital, USA, were evaluated for their sensitivity to antibiotics. Antimicrobial susceptibility testing was performed using a standardised disk diffusion assay on agar (quasi/non biofilm) and poloxamer (biofilm). Many of the Gram‐positive and ‐negative isolates demonstrated changes in susceptibility to antibiotics when grown at different pH values and phenotypic states. Findings of this study highlight the clinical relevance that both pH and the phenotypic state of bacteria have on antibiotic performance. The study in particular has shown that bacteria exhibit an enhanced tolerance to antibiotics when grown in the biofilm phenotypic state. Such a finding suggests that more appropriate antibiotic sensitivity testing for woundcare and medicine is warranted to help assist in the enhancement of positive clinical outcomes.
Keywords: Antibiotics, Biofilms, Silver, Wounds, Wound dressings
INTRODUCTION
Within the wound environment, micro‐organisms have been reported to reside in both a planktonic and sessile (biofilm) state, with the recalcitrant biofilm state considered the most significant to delayed wound healing 1, 2. Biofilms are composed of microbial cells which are encased within a matrix of extracellular polymeric substances (EPS) and attached to each other, or to a non biological or biological surface/support. Bacteria which reside in the biofilm phenotypic state are known to differ significantly from their planktonic counter parts in terms of growth rate and gene transcription. In addition, biofilm bacteria are more tolerant to antimicrobials in comparison to their planktonic counterparts (3). Consequently, antibiotics and other antimicrobials used in the management of at‐risk or infected wounds must show efficacy on micro‐organisms residing in both the planktonic and sessile states.
Antibiotics are used for a range of purposes but specifically for preventing or limiting a local or systemic infection and are routinely administered, as part of a treatment regime, for both bacterial and fungal infections in acute and chronic wounds. However, there is a growing concern worldwide on the failure of antibiotic therapies and the increasing emergence of antibiotic resistance in bacteria. Such antibiotic therapy failures have been reported to have arisen for a number of reasons including the overuse of antibiotics (4), inappropriate use in many human and animal conditions 5, 6, 7, inadequate or incorrect prescribing and non completion of a prescribed course of antibiotics by patients.
Many factors are known to affect the activity of antibiotics and antiseptics and have included pH (8), temperature, concentration, contact time, biological matter and the microbial phenotypic state 3, 9. As an example it has been found that the activity of macrolides and aminoglycosides are reduced in alkaline conditions 10, 11. Contrary to this the activity of beta‐lactam antibiotics are increased on bacteria in acidic conditions (12). A similar effect of pH on the activity of antiseptics has been shown. For example, chlorhexidine and quaternary ammonium compounds (QACs) are known to be more active at an alkaline rather than an acidic pH (13).
In addition to pH and bacterial phenotype affecting the activity and choice of antimicrobial for the management of infected wounds there is a growing concern that the overuse of some antiseptics may lead to cross resistance to certain antibiotics. Such a phenomena has been documented for an array of different antiseptics. For example, Akimitsu and colleagues (14) found that meticillin‐resistant Staphylococcus aureus (MRSA) mutants that were resistant to benzalkonium chloride also exhibited increased resistance to a number of beta‐lactam antibiotics. Further to this Yamamoto and colleagues (15) reported on a Staphylococcus aureus strain that showed resistant to a range of antibiotics and also to benzalkonium chloride and chlorhexidine. Meanwhile, Suller and Russell (16) reported on a S. aureus strain that exhibited resistance to triclosan but not to antibiotics.
Cross resistance relating to antiseptics and antibiotics is of considerable relevance to clinical practice and positive clinical outcomes. Consequently, to help reduce the risk of cross resistance occurring between antibiotics and antiseptics appropriate usage of both these agents is warranted in clinical practice.
Our goals in this paper were to (i) evaluate the antibiotic sensitivity of bacteria isolated from burn and chronic wounds and (ii) evaluate the effect of pH and bacterial phenotype on the efficacy of antibiotics.
MATERIALS AND METHODS
Test micro‐organism
Chronic and burn wound isolates which had been routinely isolated from burn and chronic wound patients were evaluated in this study. The test isolates included Gram‐positive bacteria: vancomycin‐resistant Enterococcus (VRE), meticillin‐resistant Staphylococcus aureus (MRSA), meticillin‐sensitive Staphylococcus aureus (MSSA), Streptococcus sp, Enterococcus sp and Gram‐negative bacteria: Pseudomonas aeruginosa, Acinetobacter sp and Gram‐negative rods.
Evaluated antibiotics
The following panel of antibiotics were tested: clindamycin (CC2 – 2 µg), ampicillin (AM10 – 10 µg), aztreonam (ATM30 – 30 µg) and levofloxacin (LVX5 – 5 µg). All antibiotic disks were purchased from Becton‐Dickinson (Becton‐Dickinson, Sparks, MD, USA). Appropriate standard reference strains were used to enable resistance and sensitivity claims (17).
Antibiotic efficacy testing
Each test organism was grown overnight in Tryptone Soy Broth (TSB) and then added to saline (0·85%). The inoculated saline (containing 1 × 106CFUs/ml) was then swabbed onto Mueller Hinton Agar (MHA), or poloxamer plates, according to Clinical and Laboratory Standards Institute (CLSI) guidelines (17). Each MHA (quasi/non biofilm state) or poloxamer (biofilm) plate was divided into segments to incorporate two specific antibiotic disks of either clindamycin (CC2) and ampicillin (AM10) for Gram‐positive isolates, and aztreonam (ATM30) or levofloxacin (LVX5) for Gram‐negative isolates.
To show the effect of pH on the activity of antibiotics, MHA and poloxamer plates were made to a pH of 7 or 5·5 (by the addition of hydrochloric acid or sodium hydroxide during media preparation). After incubation the zone of inhibition (ZOI) around each antibiotic disk was recorded. All experiments were carried out in triplicate.
Biofilm test method and procedure
The biofilm test model setup can be located elsewhere 18, 19, 20. Briefly, poloxamer (30%) was incorporated into Mueller Hinton Broth (MHB) and refrigerated overnight (4°C). The poloxamer suspension was then autoclaved and returned to the fridge. Liquefied poloxamer was poured into Petri dishes and then incubated overnight at 37°C before inoculation with a test isolate.
Statistical analysis
A Student's t‐test was used to compare zones of inhibition. All data were analysed using Microsoft Excel.
RESULTS
Gram‐positive wound isolates – effect of pH
Forty‐seven Gram‐positive chronic wound isolates, including, VRE, MRSA, β and α haemolytic Streptococcus sp and MSSA were exposed to antibiotics AM10 and CC2 (Figure 1). A zone of clearing around AM10 was noted for all MRSA strains at a pH of 7, with a mean ZOI of 12 mm observed. CC2 was found to be much more efficacious on MRSA strains than AM10. All eight MSSA isolates were found to be sensitive to both antibiotics AM10 and CC2 at a pH of 7·0 with a mean ZOI recorded at 20·3 and 26 mm, respectively. All three Streptococcus sp were found to be sensitive to CC2 at a pH of 7 with poorer efficacy noted for AM10. All of the 16 VRE strains showed complete resistance to AM10 and CC2 at pH 7·0 according to standard resistance classification guidelines (17).
Figure 1.
The efficacy of antibiotics ampicillin [AM10] and clindamycin [CC2] (mean ZOI [mm]) on Gram‐positive bacteria isolated from chronic wounds and grown in the quasi/non biofilm state at a pH of 7.
When a representative number of Gram‐positive chronic and burn wound isolates were exposed to antibiotics at a pH of 7 or 5·5 activity was found to be affected (Table 1). Staphylococcus aureus, including MRSA, appeared more susceptible to CC2 at a pH of 7·0 compared with pH 5·5. This however was not significant (P < 0·05). The opposite was true for sensitivity to AM10. All chronic wound Enterococcus isolates showed tolerance to AM10 at both pH 5·5 and 7. Interestingly all strains of Enterococcus sp isolated from burn wounds were found to be sensitive to both antibiotics AM10 and CC2.
Table 1.
The efficacy [mean ZOI (mm)] of antibiotics ampicillin (AM10) and clindamycin (CC2) on a representative sample of Gram‐positive wound isolates grown in the quasi/non biofilm state (±SE in brackets) at pH 5·5 and 7
Isolate | Wound type | Number | Antibiotic Mean ZOI (mm) | |||
---|---|---|---|---|---|---|
AM10 | CC2 | |||||
pH 7 (±SE) | pH 5·5 (±SE) | pH 7 (±SE) | pH 5·5 (±SE) | |||
Enterococcus sp (including VRE) | Burn | 7 | 27·6 ± 1·8 | 32·9 ± 1·3 | 9·1 ± 6·5 | 11·9 ± 8·2 |
Chronic | 6 (All VRE) | 0 | 0 | 2·7 ± 2·7 | 0 | |
Staphylococcus aureus (including MRSA) | Burn | 4 (3 MRSA) | 17·1 ± 9·7 | 28.4 ± 7·2 | 22·9 ± 7·6 | 15·8 ± 5·3 |
Chronic | 8 (5 MRSA) | 11·6 ± 1·0 | 17·6 ± 3·1 | 22·8 ± 4·1 | 13·9 ± 4·1 |
SE, standard error; ZOI, zone of inhibition.
Gram‐negative wounds isolates – effect of pH
At a pH of 7 the efficacy of ATM30 and LVX5 was increased slightly on a representative sample of Gram‐negative rods isolated from chronic wounds compared with a pH of 5·5 (Table 2). P. aeruginosa strains isolated from chronic wounds were sensitive to ATM30 with efficacy of the antibiotic increasing slightly at a pH of 7 compared with 5·5 – the opposite was true for the antibiotic LVX5.
Table 2.
The efficacy [mean ZOI (mm)] of antibiotics aztreonam (ATM30) and levofloxacin (LVX5) on a representative sample of Gram‐negative wound isolates grown at pH 5·5 and 7 in the quasi/non biofilm state
Isolate | Wound type | Number | Antibiotic Mean ZOI (mm) | |||
---|---|---|---|---|---|---|
ATM30 | LVX5 | |||||
pH 7 (± SE) | pH 5·5 (± SE) | pH 7 (± SE) | pH 5·5 (±SE) | |||
Gram‐negative rods | Chronic | 4 | 30·0 ± 3·0 | 27 ± 3·0 | 31 ± 2·0 | 29 ± 4·0 |
Acinetobacter baumannii | Burn | 4 | 8·9 ± 3·0 | 11·0 ± 4·0 | 12·5 ± 6·2 | 7·6 ± 7·6 |
Enterobacter sp | Burn | 5 | 27·3 ± 8·5 | 24·3 ± 7·6 | 26·2 ± 8·5 | 18·3 ± 6·8 |
Escherichia coli | Burn | 6 | 33·1 ± 1·0 | 28·7 ± 1·2 | 28·9 ± 7·0 | 18·3 ± 8·0 |
Klebsiella sp | Burn | 4 | 33·4 ± 0·8 | 20·1 ± 7·1 | 31·8 ± 0·7 | 22·1 ± 1·6 |
Proteus mirabilis | Burn | 3 | 41 ± 0·3 | 41 ± 1·7 | 30·3 ± 7·8 | 31·2 ± 9·1 |
Pseudomonas aeruginosa | Chronic | 2 | 18 ± 6·0 | 14·25 ± 14·0 | 12 ± 12·0 | 14 ± 14·0 |
Burn | 5 | 19·6 ± 1·4 | 19·8 ± 5·0 | 18·4 ± 2·2 | 18·1 ± 5·0 |
SE, standard error; ZOI, zone of inhibition.
Five strains of P. aeruginosa isolated from burn wounds were exposed to ATM30 and LVX5. The average ZOI for ATM30 was calculated to be 19·6 mm at a pH of 7 and 19·8 mm at a pH of 5·5. For LVX5 the zones of inhibition were very similar at pH of 7 and 5·5.
Four strains of Acinetobacter baumannii isolated from burn wounds showed a slight increased sensitivity to ATM30 at a pH of 5·5 compared with a pH of 7. However, the opposite was true for LVX5. For all Enterobacter sp, E. coli and Klebsiella sp screened against ATM30 and LVX5 the activity of both antibiotics was enhanced at a pH of 7 compared with a pH of 5·5. However, this increased sensitivity was not significant (P < 0·05). Proteus mirabilis isolates showed equal sensitivity to ATM30 and LVX5 at both pH of 7 and 5·5.
Gram‐positive wound isolates – effect of phenotypic state
All Gram‐positive bacteria, apart from one strain of S. aureus isolated from chronic wounds, were found to have a slightly increased tolerance to AM10 and CC2 when grown in the biofilm state compared with the quasi/non biofilm state (Table 3). This effect was however not found to be significant (P < 0·05). The mean CZOI for the burn wound Enterococcus isolates was found to be significantly larger (P < 0·05) for the antibiotic AM10 when the isolates were grown in the quasi/non biofilm state and compared with the mean CZOI in the biofilm state. For the chronic wound MRSA isolates the efficacy of CC2 was significantly reduced (P < 0·05) when the bacteria were grown in the biofilm state compared with growth in the quasi/non biofilm state.
Table 3.
A comparison of the efficacy [mean ZOI (mm)] of antibiotics ampicillin (AM10) and clindamycin (CC2) on Gram‐positive chronic and burn wound isolates grown in the quasi/non biofilm and biofilm phenotypic states
Isolate | Wound type | Number | Antibiotic Mean ZOI (mm) | |||
---|---|---|---|---|---|---|
AM10 | CC2 | |||||
Non biofilm (±SE) | Biofilm (±SE) | Non biofilm (±SE) | Biofilm (±SE) | |||
Gram positive | ||||||
Enterococcus sp | Burn | 7 | 27·6 ± 1·7 | 17·7 ± 3·2 * | 9·1 ± 4·7 | 6·4 ± 4·0 |
Enterococcus sp (VRE) | Chronic | 5 | 0 | 0 | 5·1 ± 5·1 | 2·9 ± 2·9 |
Staphylococcus aureus (3 MRSA) | Burn | 4 | 17·1 ± 9·7 | 13·1 ± 6·4 | 22·9 ± 7·6 | 15·6 ± 1·4 |
MRSA | Chronic | 5 | 11·5 ± 1·4 | 4·8 ± 2·0 | 26·1 ± 2·2 | 12·1 ± 3·1 * |
Staphylococcus aureus | Chronic | 2 | 11.0 ± 1·0 | 12.0 ± 1·3 | 14·5 ± 14·5 | 7·3 ± 7·3 |
SE, standard error; ZOI, zone of inhibition.
*Significantly different at 95% confidence interval.
Gram‐negative wound isolates – effect of phenotypic state
P. aeruginosa strains isolated from both chronic and burn wounds showed an increased tolerance to ATM30 when grown in the biofilm phenotypic state (Table 4). These results however were found not to be significant. For the antibiotic LVX5 enhanced tolerance in the biofilm state was not showed for the chronic wound isolates. For all other Gram‐negative strains, isolated from chronic wounds, tolerance to both ATM30 and LVX5 when grown in the biofilm phenotypic state was showed when compared with growth in the quasi/non biofilm state.
Table 4.
A comparison of the efficacy [mean ZOI (mm)] of antibiotics aztreonam (ATM30) and levofloxacin (LVX5) on Gram‐negative chronic and burn wound isolates grown in the quasi/non biofilm and biofilm phenotypic states
Isolate | Wound type | Number | Antibiotic Mean ZOI (mm) | |||
---|---|---|---|---|---|---|
ATM30 | LVX5 | |||||
Non biofilm (±SE) | Biofilm (±SE) | Non biofilm (±SE) | Biofilm (±SE) | |||
Acinetobacter baumannii | Burn | 4 | 8·9 ± 3·0 | 9·9 ± 3·3 | 12·4 ± 6·2 | 13·0 ± 4·7 |
Enterobacter sp | Burn | 5 | 26·9 ± 6·7 | 15·7 ± 4·1 * | 25·5 ± 7·3 | 20·7 ± 0·9 |
Escherichia coli | Burn | 6 | 33·1 ± 1·0 | 19·1 ± 0·4 * | 28·9 ± 7·0 | 19·5 ± 3·0 * |
Klebsiella sp | Burn | 4 | 31·8 ± 0·7 | 21·5 ± 1·8 * | 33·4 ± 0·8 | 24·8 ± 1·4 * |
Proteus sp | Burn | 3 | 41·0 ± 0·3 | 22.0 ± 0·8 * | 30·3 ± 7·8 | 19·5 ± 2·2 |
Pseudomonas aeruginosa | Burn | 5 | 19·6 ± 1·4 | 13·9 ± 0·8 | 18·4 ± 2·2 | 17·0 ± 2·1 |
Chronic | 2 | 18·0 ± 6·0 | 13·5 ± 3·0 | 12·0 ± 12·0 | 14·3 ± 6·3 | |
Gram‐negative rods | Chronic | 4 | 27·4 ± 2·9 | 17·9 ± 1·6 | 30·0 ± 2·3 | 20·8 ± 1·1 |
SE, standard error; ZOI, zone of inhibition.
*Significantly different at 95% confidence interval.
For the burn isolates Enterobacter sp, E. coli, Klebsiella sp, Pseudomonas sp and Proteus sp the mean zones of inhibition around antibiotics ATM30 and LVX5 were overall smaller when grown in the biofilm phenotypic state compared with the quasi/non biofilm state.
When Acinetobacter baumannii was grown in the non biofilm state and compared with growth in the biofilm phenotypic state both ATM30 and LVX5 exhibited similar efficacies irrespective of phenotypic state.
Overall, increased tolerance to antibiotics in the biofilm phenotypic state was showed to be significantly different (P < 0·05) for Enterococcus sp (ATM30), E. coli (ATM30 and LVX5), Klebsiella sp (ATM30 and LVX5) and Proteus sp (ATM30).
DISCUSSION
Wounds are known to harbour a complex population of microorgansisms which create and maintain conditions in the wound that prevent them from healing in a timely manner (21). To help reduce the microbiological colonisation of a wound, systemic and topical antibiotics are often administered (22).
In this study we evaluated chronic and burn wound isolates for their sensitivity to commonly used antibiotics administered in woundcare. The main goal was to determine whether the activity of antibiotics was affected by both pH and bacterial phenotypic state. Firstly the sensitivity of Gram‐positive bacteria to CC2 and AM10 was evaluated. AM10 and CC2 are used extensively in the treatment of bacterial infections caused by Gram‐positive organisms such as, staphylococci and streptococci specifically, although AM10 has showed activity against Gram‐negative organisms such as coliforms and Proteus sp (23). ATM30 and LVX5 were evaluated for their effectiveness on Gram‐negative isolates. ATM30 is a synthetic monocyclic beta‐lactam antibiotic that has strong activity against Gram‐negative bacteria, including P. aeruginosa, Citrobacter sp, Enterobacter sp, E coli, Klebsiella sp, Proteus sp and Serratia sp (24). However, it has been shown to have poor, if any, activity on Gram‐positive bacteria. LVX5 is a broad‐spectrum antibiotic that has been found to be active against both Gram‐positive and Gram‐negative bacteria.
The majority of studies that have evaluated the antimicrobial performance of antibiotics and antimicrobials have, in general, only investigated their ability to prevent the growth of quasi/non biofilm or planktonic micro‐organisms. Consequently, in this study we wanted to evaluate performance of antibiotics on bacteria grown in the biofilm phenotypic state. The in vitro model that we used to assess the effect of antimicrobials on biofilms is one that has been published widely and employed the use of a biofilm stimulating matrix of poloxamer 18, 25, 26, 27, 28, 29, 30.
The study found that the effectiveness and sensitivity of bacteria to antibiotics was affected slightly by both pH and bacterial phenotype. In particular, it was found that the activity of ampicillin on MRSA grown in the quasi/non biofilm phenotypic state increased when pH was decreased to 5·5 compared with a pH of 7·0. In addition many bacteria grown within the biofilm phenotypic state showed enhanced tolerance to antibiotics when compared with their planktonic counterparts. Evaluating bacterial susceptibility to antibiotics within the biofilm phenotypic state is considered more clinically representative than evaluating the activity of antimicrobials on bacteria within the planktonic or non biofilm phenotypic state (18). In addition the study has showed that all antibiotics exhibited variations in their activity against species and genera of chronic and burn wound bacteria. In particular it was found that for the Gram‐negative isolates antibiotics remained efficacious.
In vitro antimicrobial susceptibility testing is very important in medicine and woundcare and is used to help predict the in vivo success or failure of antibiotic therapy. The in vitro testing of the efficacy of an antibiotic is performed under standardized conditions following appropriate guidelines to ensure that the results are reproducible and useful. All in vitro results are interpreted on available CLSI (17) data. The results generated help to guide antibiotic choice. However, any in vitro antimicrobial susceptibility testing should be combined with clinical information and experience when selecting the most appropriate antibiotic for a patient. The susceptibility of bacteria to a specific antibiotic implies that the isolate is inhibited by the usually achievable concentrations of antimicrobial agent. However, this definition says nothing about the chances of clinical success. The resistance of an isolate to an antibiotic suggests that it is inhibited by the usual concentrations of the antibiotic used. The zone diameters generated have to fall within a certain range where specific microbial resistance mechanisms are likely to occur, and clinical efficacy of the agent against the isolate has not been reliably shown in treatment studies. These ranges are specified by the CLSI(17) and updated regularly. Therefore within this study whilst a small number of isolates exhibited very small ZOI these isolates were still classified as resistant under present guidelines. However, unlike antibiotic sensitivity testing for planktonic and quasi/non biofilm bacteria, appropriate guidelines and standards for evaluating antibiotics against biofilms do not exist. Consequently, such an approach is required to help guide appropriate antibiotic usage for those infections known to be biofilm related.
Overall, findings of this study highlight the clinical relevance that both pH and the phenotypic state of bacteria have on antibiotic performance. The study has showed that bacteria exhibit an enhanced tolerance to antibiotics when grown in the biofilm phenotypic state. Such a finding suggests that more appropriate antibiotic sensitivity testing for woundcare and medicine in general is warranted to help assist in the enhancement of positive clinical outcomes. Whilst the in vitro models and conditions used in this study were remote from those prevailing in a patient with a chronic or burn wounds the results achieved may nevertheless help to further enhance our present understanding of how the activity of antibiotics could be improved for clinical practices. Strategies are warranted to help increase the efficacy of antibiotics on the microbial bioburden and infection in wounds. Consequently, based on the findings in this study it appears that if we adopt more robust in vitro biofilm models which are more appropriate and relevant to the in vivo situation, and investigate the variables that affect antimicrobial performance better clinical outcomes for the patient could potentially be achieved.
REFERENCES
- 1. Percival SL, Hill KE, Malic S, Thomas DW, Williams DW. Antimicrobial tolerance and the significance of persister cells in recalcitrant chronic wound biofilms. Wound Repair Regen 2011;19:1–9. [DOI] [PubMed] [Google Scholar]
- 2. Wolcott RD, Rhoads DD, Bennett ME, Wolcott BM, Gogokhia L, Costerton JW, Dowd SE. Chronic wounds and the medical biofilm paradigm. J Wound Care 2010;19:45–6, 48–50, 52–3. [DOI] [PubMed] [Google Scholar]
- 3. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clinical Microbiol Rev 2002;15:167–93. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Levy SB. Factors impacting on the problem of antibiotic resistance. J Antimicrob Chemother 2002;49: 25–30. [DOI] [PubMed] [Google Scholar]
- 5. Gorbach SL. Antimicrobial use in animal feed – time to stop. N Engl J Med 2001;345:1202–3. [DOI] [PubMed] [Google Scholar]
- 6. White DG, Zhao S, Sudler R, Ayers S, Friedman S, Chen S, McDermott PF, McDermott S, Wagner DD, Meng J. The isolation of antibiotic‐resistant salmonella from retail ground meats. N Engl J Med 2001;345:1147–54. [DOI] [PubMed] [Google Scholar]
- 7. Nelson JM, Chiller TM, Powers JH, Angulo FJ. Fluoroquinolone‐resistant Campylobacter species and the withdrawal of fluoroquinolones from use in poultry: a public health success story. Clin Infect Dis 2007;44:977–80. [DOI] [PubMed] [Google Scholar]
- 8. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action and resistance. Clin Microbiol Rev 1999;12:147–79. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Simmen HP, Battaglia H, Kossmann T, Blaser J. Effect of peritoneal fluid pH on outcome of aminoglycoside treatment of intraabdominal infections. Worl J Surg 1993;17:393–7. [DOI] [PubMed] [Google Scholar]
- 10. Debets‐Ossenkopp YJ, Namavar F, MacLaren DM. Effect of an acidic environment on the susceptibility of Helicobacter pylori to trospectomycin and other antimicrobial agents. Eur J Clin Microbiol Infect Dis 1995;14:353–5. [DOI] [PubMed] [Google Scholar]
- 11. Falagas ME, McDermott L, Snydman DR. Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group. Antimicrobial Agents Chemother 1997;41:2047–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Barcia‐Macay M, Seral C, Mingeot‐Leclercq MP, Tulkens PM, van Bambeke F. Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP‐1 macrophages. Antimicrob Agents Chemother 2006;50:841–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Russell AD. Biocide use and antibiotic resistance: the relevance of laboratory findings to clinical and environmental situations. Lancet Infect Dis 2003;3:794–803. [DOI] [PubMed] [Google Scholar]
- 14. Akimitsu N, Hamamoto H, Inoue R, Shoji M, Akamine A, Takemori K, Hamasaki N, Sekimizu K. Increase in resistance of methicillin‐resistant Staphylococcus aureus to beta‐lactams caused by mutations conferring resistance to benzalkonium chloride, a disinfectant widely used in hospitals. Antimicrob Agents Chemother 1999;43:3042–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Yamamoto T, Tamura Y, Yokota T. Antiseptic and antibiotic resistance plasmid in Staphylococcus aureus that possesses ability to confer chlorhexidine and acrinol resistance. Antimicrob Agents Chemother 1988;32:932–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Suller MT, Russell AD. Triclosan and antibiotic resistance in Staphylococcus aureus. J Antimicrob Chemother 2000;46:11–8. [DOI] [PubMed] [Google Scholar]
- 17. CLSI. Performance standards for antimicrobial susceptibility testing, seventeenth informational supplement, document M100‐S17. Wayne, PA: Clinical and Laboratory Standards Institute, 2007. [Google Scholar]
- 18. Clutterbuck AL, Cochrane CA, Dolman J, Percival SL. Evaluating antibiotics for use in medicine using a poloxamer biofilm model. Ann Clin Microbiol Antimicrob 2007;6:2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Percival SL, Bowler PG, Dolman J. Antimicrobial activity of silver‐containing dressings on wound microorganisms using an in vitro biofilm model. Int Wound J 2007;4:186–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Percival SL, Slone W, Linton S, Okel T, Corum L, Thomas JG. The antimicrobial efficacy of a silver alginate dressing against a broad spectrum of clinically relevant wound isolates. Int Wound J 2011;8:237–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Percival SL, Dowd S. Microbiology of Wounds. In: Percival SL, Cutting K, editors. Microbiology of Wounds. New York: CRC Press, 2010. [Google Scholar]
- 22. Percival SL, Cooper R, Lipsky B. Antimicrobials and wounds. In: Percival SL, Cutting K, editors. Microbiology of wounds. New York: CRC Press, 2010. [Google Scholar]
- 23. Daum RS. Clinical practice. Skin and soft‐tissue infections caused by methicillin‐resistant Staphylococcus aureus. N Engl J Med 2007;357:380–90. [DOI] [PubMed] [Google Scholar]
- 24. Maheswaran AM. Mosby's drug consult 2006, 16th edn. St. Louis, MO: Elsevier Mosby, 2006. [Google Scholar]
- 25. Gilbert P, Jones MV, Allison DG, Heys S, Maira T, Wood P. The use of poloxamer hydrogels for the assessment of biofilm susceptibility towards biocide treatments. J Appl Microbiol 1998;85: 985–90. [DOI] [PubMed] [Google Scholar]
- 26. Wirtanen G, Salo S, Allison DG, Mattila‐Sandholm T, Gilbert P. Performance evaluation of disinfectant formulations using poloxamer‐hydrogel biofilm‐constructs. J Appl Microbiol 1998;85:965–71. [DOI] [PubMed] [Google Scholar]
- 27. Sincock SA, Rajwa B, Robinson PJ. Characteristics and dynamics of bacterial populations with poloxamer hydrogel biofilm constructs. Abstract International Society for Analytical Cytology XX International Congress, May 20–25, 2000, Le Corum, Montpellier, France. 6451.
- 28. Kim MM, Park HK, Kim SN, Kim HD, Kim YH, Rang MJ, Ahn HJ, Hwang JK. Effect of a new antibacterial agent, xanthorrhizol on the viability of plaque biofilm. Poster IADR/AADR/CADR 80th, San Diego, March 6–9 2002.
- 29. MacLehose HG, Gilbert P, Allison DG. Biofilms, homoserine lactones and biocide susceptibility. J Antimicrob Chemother 2004;53:180–4. [DOI] [PubMed] [Google Scholar]
- 30. Rickard AH, Gilbert P, Handley PS. Influence of growth environment on coaggregation between freshwater biofilm bacteria. J Appl Microbiol 2004;96:1367–73. [DOI] [PubMed] [Google Scholar]